Who Supplies Sorafenib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Sorafenib exports, with 203+ registered manufacturers shipping to buyers across 98+ countries — yet a handful of companies dominate the shipments. TORRENT PHARMACEUTICALS LTD holds the largest share at 27.2% (export value: $4.5M). Close behind, NATCO PHARMA LIMITED (27.2%, $4.5M). MEDYRA PHARMACEUTICAL (19.1%, $3.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Sorafenib? Top Manufacturers & Their Buyers
Flow of Sorafenib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Sorafenib Supplier Network — Key Market Intelligence
The Sorafenib export market from India is led by TORRENT PHARMACEUTICALS LTD, which alone commands a 27.2% share, shipping $4.5M worth of product across 12 shipments. The second-largest exporter, NATCO PHARMA LIMITED, contributes $4.5M (27.2%) to the overall market. Combined, the top two suppliers alone account for 54.3% of all Sorafenib exports, indicating a relatively concentrated supply base.
Across all 203 tracked manufacturers, the total Sorafenib export value stands at $16.6M from 916 shipments. The market average shipment value is $18.2K. The single largest buyer relationship in terms of trade value is XX RXXDY XXLABXXATOX, receiving $4.5M worth of product.
The combined buyer network spans 12 named purchasing companies, including XX RXXDY XXLABXXATOX, DR REDDY S LABORATOR, TORRENT PHARMA INC, TORRENT DO BRASIL LT, BOSTON ONCOLOGY ARAB and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the first-largest Sorafenib exporter from India, with a market share of 27.2% and a total export value of $4.5M across 12 shipments. Their average shipment value of $376.7K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
TORRENT PHARMACEUTICALS LTD serves 1 named buyer in our database. XX RXXDY XXLABXXATOX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XX RXXDY XXLABXXATOX — $4.5M across 12 shipments (100.0% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $376.7K is 1973% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
2NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the second-largest Sorafenib exporter from India, with a market share of 27.2% and a total export value of $4.5M across 17 shipments. Their average shipment value of $265.8K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 1 named buyer in our database. DR REDDY S LABORATOR is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• DR REDDY S LABORATOR — $4.5M across 17 shipments (100.0% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $265.8K is 1363% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
3MEDYRA PHARMACEUTICAL
MEDYRA PHARMACEUTICAL is the third-largest Sorafenib exporter from India, with a market share of 19.1% and a total export value of $3.2M across 15 shipments. Their average shipment value of $211.7K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
MEDYRA PHARMACEUTICAL serves 3 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 54.9% of this supplier's tracked business. Top customers include:
• TORRENT PHARMA INC — $1.7M across 8 shipments (54.9% of this supplier's total exports)
• TORRENT PHARMA INC — $1.4M across 7 shipments (45.1% of this supplier's total exports)
• TORRENT DO BRASIL LT — $3 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: MEDYRA PHARMACEUTICAL's per-shipment value of $211.7K is 1065% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
4HEET HEALTHCARE PRIVATE LIMITED
HEET HEALTHCARE PRIVATE LIMITED is the fourth-largest Sorafenib exporter from India, with a market share of 9.5% and a total export value of $1.6M across 34 shipments. Their average shipment value of $46.3K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
HEET HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. BOSTON ONCOLOGY ARAB is the dominant customer, accounting for 68.2% of this supplier's tracked business. Top customers include:
• BOSTON ONCOLOGY ARAB — $1.1M across 23 shipments (68.2% of this supplier's total exports)
• SOPHAL SPA — $275.6K across 6 shipments (17.5% of this supplier's total exports)
• ATLANTA MEDICARE CO LTD — $134.8K across 3 shipments (8.6% of this supplier's total exports)
• ATLANTA MEDICARE CO LTD — $78.1K across 2 shipments (5.0% of this supplier's total exports)
• EVEREST BANK LTD — $11.7K across 0 shipments (0.7% of this supplier's total exports)
Key Insight: HEET HEALTHCARE PRIVATE LIMITED's per-shipment value of $46.3K is 155% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
5JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Sorafenib exporter from India, with a market share of 3.0% and a total export value of $492.0K across 4 shipments. Their average shipment value of $123.0K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 2 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FARMA SOLUTION SA — $246.0K across 2 shipments (50.0% of this supplier's total exports)
• NEOETHICALS S A — $246.0K across 2 shipments (50.0% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $123.0K is 577% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
6CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Sorafenib exporter from India, with a market share of 2.6% and a total export value of $436.1K across 3 shipments. Their average shipment value of $145.4K is above the market average of $18.2K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 2 named buyers in our database. DROGUERIA SAIMED S.A is the dominant customer, accounting for 53.7% of this supplier's tracked business. Top customers include:
• DROGUERIA SAIMED S.A — $234.3K across 2 shipments (53.7% of this supplier's total exports)
• FARMA SOLUTION, SOCI — $201.8K across 1 shipments (46.3% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $145.4K is 700% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Sorafenib Flows
Once Sorafenib leaves the manufacturing plants of companies like TORRENT PHARMACEUTICALS LTD and NATCO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $16.6M. United States absorbs the largest share at 75.0% ($12.5M), followed by Saudi Arabia (6.5%) and Guatemala (2.7%).
In United States — the top destination — named importers include TORRENT PHARMA INC, TORRENT PHARMA INC,.
This geographic spread reflects Sorafenib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Sorafenib Go? Top Importing Countries & Their Buyers
Trade flow of Sorafenib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Sorafenib imports from India, with a total trade value of $12.5M across 12 shipments — representing a 75.0% share of all Sorafenib exports. The average shipment value of $1.0M is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Sorafenib importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 16.0% ($2.0M) of this market's total imports.
• TORRENT PHARMA INC — $2.0M (16.0% of United States's total)
• TORRENT PHARMA INC, — $1.4M (11.5% of United States's total)
Key Insight: United States's per-shipment average of $1.0M (5627% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Sorafenib imports from India.
2Saudi Arabia
Saudi Arabia ranks as the second-largest destination for Sorafenib imports from India, with a total trade value of $1.1M across 0 shipments — representing a 6.5% share of all Sorafenib exports. The average shipment value of $1.1M is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Saudi Arabia's per-shipment average of $1.1M (5826% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Sorafenib imports from India.
3Guatemala
Guatemala ranks as the third-largest destination for Sorafenib imports from India, with a total trade value of $447.9K across 0 shipments — representing a 2.7% share of all Sorafenib exports. The average shipment value of $447.9K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Guatemala's per-shipment average of $447.9K (2365% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Guatemala is a key market for Sorafenib imports from India.
4France
France ranks as the fourth-largest destination for Sorafenib imports from India, with a total trade value of $275.6K across 0 shipments — representing a 1.7% share of all Sorafenib exports. The average shipment value of $275.6K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: France's per-shipment average of $275.6K (1417% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Sorafenib imports from India.
5Nicaragua
Nicaragua ranks as the fifth-largest destination for Sorafenib imports from India, with a total trade value of $264.4K across 0 shipments — representing a 1.6% share of all Sorafenib exports. The average shipment value of $264.4K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Nicaragua's per-shipment average of $264.4K (1356% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nicaragua is a key market for Sorafenib imports from India.
People Also Ask — Sorafenib Supplier & Trade Network
Who are the top suppliers of Sorafenib from India?+
Which companies buy Sorafenib from Indian manufacturers?+
Where does Sorafenib exported from India go?+
What is the market share of the top Sorafenib supplier from India?+
What is the average shipment value for Sorafenib exports from India?+
Is Sorafenib manufactured in India and exported globally?+
Which country imports the most Sorafenib from India?+
Who are the buyers of Sorafenib in Saudi Arabia?+
How concentrated is the Sorafenib supplier market in India?+
How do I find verified buyers for Sorafenib in specific countries?+
Sorafenib Trade Network — Key Takeaways
- 1TORRENT PHARMACEUTICALS LTD is India's dominant Sorafenib exporter with a 27.2% market share and $4.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 203 suppliers collectively account for 88.4% of all tracked Sorafenib exports, with a combined trade value of $16.6M.
- 3United States is the largest destination market, absorbing 75.0% of India's Sorafenib exports ($12.5M). Saudi Arabia (6.5%) and Guatemala (2.7%) follow.
- 4With 916 total shipments averaging $18.2K each, the Sorafenib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include XX RXXDY XXLABXXATOX, DR REDDY S LABORATOR, TORRENT PHARMA INC, TORRENT PHARMA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 98 countries
Network value: $16.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sorafenib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Sorafenib.
- 2.Flow Mapping: 203 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 916 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 98 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
916 Verified Shipments
203 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists